(2013) Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans J Endocrinol Metab 3(12):715 AOD9604 vs Related GH-Axis Research Tools AOD9604s unique combination of GH receptor independence, direct lipolytic activity, absence of IGF-1 stimulation, and confirmed oral bioavailability makes it an irreplaceable research tool for studying adipose tissue metabolism and lipolysis without the systemic endocrine confounds associated with intact hGH or indirect GH secretagogues
In research models, it has been shown to enhance fat oxidation , reduce adiposity , and improve insulin sensitivity
For humans, 5-Amino-1MQ is still in the experimental stage, but anecdotal reports and early user experiences are trickling in
Research community discussions most often use 50 to 150 mg by mouth each day, while subcutaneous examples use much smaller amounts
Measurements change
Every compound from BioLongevity Labs ships with a COA tied to its specific batch, so researchers can confirm exactly what they received before it enters a protocol